<DOC>
	<DOCNO>NCT02278146</DOCNO>
	<brief_summary>A multi-center , open-label , prospective , feasibility study evaluate ParaPatch System treatment urinary incontinence overactive bladder .</brief_summary>
	<brief_title>Feasibility Study Evaluating ParaPatch System</brief_title>
	<detailed_description>- Baseline Period The baseline period allow washout medication affect bladder function allow subject begin void diary . - Prospective data collection take place form void diary . Leak frequency , relevant parameter collect . - Inclusion/exclusion criterion rechecked end baseline . - Qol questionnaire complete office end baseline period . - Evaluation Period During evaluation period , subject use ParaPatch System . - No medication affect bladder function allow evaluation period . - Subjects complete void diary , evaluation period . Data capture include : adverse event , medication use , leak frequency relevant parameter . - Qol questionnaire complete office end evaluation period . - Follow-up Period Subjects follow evaluation period check residual Adverse Events . - No medication affect bladder function allow follow-up period . - Subjects call clinical coordinator end Follow-up period ask potential Adverse Events .</detailed_description>
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<criteria>Women age &gt; 18 &lt; 75 year old . Subject ability read comprehend English , reliably record information require Protocol , include proper completion questionnaire . Subject able provide write informed consent prior participation study . Diagnosed either follow : ) overactive bladder , b ) urinary stress incontinence . Are currently participate participate within past 30 day clinical investigation involve impact urinary renal function . Subject demonstrate believe risk noncompliance study procedure ( e.g. , complete diary returning require followup visit ) . Subject undergone onabotulinumtoxinA injection bladder last twelve ( 12 ) month . Subject suitable study reason ( include overall health , preexist condition medication ) judgment investigator . Have untreated recurrent urinary tract infection ( &gt; 2 time within past 6 month ) . Have neurogenic disorder Multiple Sclerosis , ALS , Parkinson Disease . Patients diagnosis painful bladder syndrome , pelvic pain interstitial cystitis .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>